2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer

OBJECTIVES/SPECIFIC AIMS: To understand the role of PGF2a and to characterize a novel cyclooxyrgenase (COX)-independent prostaglandin synthesis pathway in epithelial ovarian cancer. METHODS/STUDY POPULATION: We used high grade epithelial ovarian cancer cell line (OVCAR3) as a model to study our path...

Full description

Bibliographic Details
Main Authors: Muhan Hu, Ekta Tiwary, Rebecca Arend, Michael Miller
Format: Article
Language:English
Published: Cambridge University Press 2018-06-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866118001036/type/journal_article
_version_ 1811156745710469120
author Muhan Hu
Ekta Tiwary
Rebecca Arend
Michael Miller
author_facet Muhan Hu
Ekta Tiwary
Rebecca Arend
Michael Miller
author_sort Muhan Hu
collection DOAJ
description OBJECTIVES/SPECIFIC AIMS: To understand the role of PGF2a and to characterize a novel cyclooxyrgenase (COX)-independent prostaglandin synthesis pathway in epithelial ovarian cancer. METHODS/STUDY POPULATION: We used high grade epithelial ovarian cancer cell line (OVCAR3) as a model to study our pathway. Our main mode of PGF2a detection is through mass spectrometry. RESULTS/ANTICIPATED RESULTS: Our current results suggest the OVCAR3 cells may synthesize PGF2a independently of COX enzymes. We anticipate this novel pathway may be dependent on the TGFb pathway. DISCUSSION/SIGNIFICANCE OF IMPACT: Understanding the role and synthesis pathway of PGF2a may allow us to uncover a novel therapeutic pathway for high grade ovarian cancer.
first_indexed 2024-04-10T04:55:17Z
format Article
id doaj.art-e77e2e9da4ca4a89b07f2f8d722eb518
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:55:17Z
publishDate 2018-06-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-e77e2e9da4ca4a89b07f2f8d722eb5182023-03-09T12:30:17ZengCambridge University PressJournal of Clinical and Translational Science2059-86612018-06-012222210.1017/cts.2018.1032336 Novel PGF2a synthesis pathway in epithelial ovarian cancerMuhan Hu0Ekta Tiwary1Rebecca Arend2Michael Miller3University of Alabama at BirminghamUniversity of Alabama at BirminghamUniversity of Alabama at BirminghamUniversity of Alabama at BirminghamOBJECTIVES/SPECIFIC AIMS: To understand the role of PGF2a and to characterize a novel cyclooxyrgenase (COX)-independent prostaglandin synthesis pathway in epithelial ovarian cancer. METHODS/STUDY POPULATION: We used high grade epithelial ovarian cancer cell line (OVCAR3) as a model to study our pathway. Our main mode of PGF2a detection is through mass spectrometry. RESULTS/ANTICIPATED RESULTS: Our current results suggest the OVCAR3 cells may synthesize PGF2a independently of COX enzymes. We anticipate this novel pathway may be dependent on the TGFb pathway. DISCUSSION/SIGNIFICANCE OF IMPACT: Understanding the role and synthesis pathway of PGF2a may allow us to uncover a novel therapeutic pathway for high grade ovarian cancer.https://www.cambridge.org/core/product/identifier/S2059866118001036/type/journal_article
spellingShingle Muhan Hu
Ekta Tiwary
Rebecca Arend
Michael Miller
2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer
Journal of Clinical and Translational Science
title 2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer
title_full 2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer
title_fullStr 2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer
title_full_unstemmed 2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer
title_short 2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer
title_sort 2336 novel pgf2a synthesis pathway in epithelial ovarian cancer
url https://www.cambridge.org/core/product/identifier/S2059866118001036/type/journal_article
work_keys_str_mv AT muhanhu 2336novelpgf2asynthesispathwayinepithelialovariancancer
AT ektatiwary 2336novelpgf2asynthesispathwayinepithelialovariancancer
AT rebeccaarend 2336novelpgf2asynthesispathwayinepithelialovariancancer
AT michaelmiller 2336novelpgf2asynthesispathwayinepithelialovariancancer